AtriCure Earnings & Forecasts

AtriCure (ATRC) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

분기별 실적 서프라이즈 금액

회계 분기	보고된 날짜	실제 EPS	예상 EPS	놀라다 %
Q2	Jul 23, 2026	$0.18	$0.03	500.0 %
Q1	May 5, 2026	$0	$-0.06	100.0 %
Q4	Feb 17, 2026	$0.06	$-0.04	250.0 %
Q3	Oct 29, 2025	$-0.01	$-0.11	90.9 %

Quarterly Revenue (Billions)

분기별 수익 깜짝 금액

회계 분기	보고된 날짜	실제 수익	예상 수익	놀라다 %
Q2	Jul 23, 2026	$153.60M	$151.77M	1.20 %
Q1	May 5, 2026	$141.25M	$139.67M	1.13 %
Q4	Feb 17, 2026	$140.50M	$140.06M	0.31 %
Q3	Oct 29, 2025	$134.27M	$131.36M	2.21 %

AtriCure Guidance

AtriCure (ATRC)은 지난 7월 23, 2026에 fiscal year 2026의 실적 전망을 발표했습니다. 회사는 주당순이익을 $0.24 - $0.32 범위로 전망했으며, 이는 시장 컨센서스 EPS 추정치인 $0.12보다 높은 수치입니다. AtriCure는 또한 해당 기간의 매출을 $602M - $610M 범위로 전망했습니다.

이전 가이던스와 비교하여 AtriCure는 주당순이익(EPS) 전망치를 이전 범위인 상향 조정됨에서 $0 - $0.04로 상향 조정했습니다. 매출 측면에서는 회사가 매출 전망치를 이전 범위인 유지됨에서 $600M - $610M로 상향 조정했습니다.

AtriCure은 29과 11월 1, 2022 사이에 7월 23, 2026개의 지침 업데이트를 발표했습니다. During this period, the company raised its outlook 14 times and lowered it 5 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.03	$-0.06	$-0.04	$-0.11
Actual	$0.18	$0.00	$0.06	$-0.01
Surprise	+500.0%	+100.0%	+250.0%	+90.9%
Revenue
Estimate	$151.8M	$139.7M	$140.1M	$131.4M
Actual	$153.6M	$141.2M	$140.5M	$134.3M
Surprise	+1.20%	+1.13%	+0.31%	+2.21%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.01	$0.09	$-0.05	$0.21
Revenue
Consensus	$151.2M	$160.1M	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
AtriCure Raises FY2026 GAAP EPS Guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 Est

AtriCure (NASDAQ:ATRC) raises FY2026 GAAP EPS guidance from $0.00-$0.04 to $0.05-$0.13 vs $0.05 analyst estimate..

Benzinga Newsdesk

PRO
AtriCure Q2 Adj. EPS $0.18 Beats $0.00 Estimate, Sales $153.600M Beat $151.842M Estimate

AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 1000 percent increase over losses of $(0.02) per share from the

Benzinga Newsdesk

PRO
AtriCure Raises FY2026 Adj EPS Guidance from $0.00-$0.04 to $0.24-$0.32 vs $0.06 Est; Raises FY2026 Sales Guidance from $600.000M-$610.000M to $602.000M-$610.000M vs $604.990M Est

AtriCure (NASDAQ:ATRC) raises FY2026 Adj EPS guidance from $0.00-$0.04 to $0.24-$0.32 vs $0.06 analyst estimate. Raises FY2026 sales outlook from $600.000 million-$610.000 million to $602.000 million-$610.000 million vs

Benzinga Newsdesk

Earnings Scheduled For July 23, 2026

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report

Benzinga Insights

PRO
AtriCure Lowers FY2026 Adj EPS Guidance from $0.09-$0.15 to $0.00-$0.04 vs $0.07 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $604.053M Est

2026 Financial GuidanceFull year 2026 revenue is projected to be approximately $600 million to $610 million, and management also projects full year 2026 Adjusted EBITDA of approximately $80 million to $82 million.

Benzinga Newsdesk

PRO
AtriCure Q1 Adj. EPS $0.00 Beats $(0.06) Estimate, Sales $141.249M Beat $139.812M Estimate

AtriCure (NASDAQ:ATRC) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.06) by 100 percent. This is a 100 percent increase over losses of $(0.14) per share from the same

Benzinga Newsdesk

AtriCure Inc